Pipeline Value Demonstration Manager (Fixed term)

Takeda; Greater London; On-site; GBP 100,000 - 125,000; Full time

Job summary

A global pharmaceutical company is seeking a Pipeline Value Demonstration Manager for a 12-month fixed-term position in London. This role involves delivering strategic recommendations for pipeline assets and requires expertise in health technology appraisal methods. Responsibilities include supporting clinical development programs and ensuring evidence generation aligns with market access strategies. Ideal candidates will have strong interpersonal skills and experience in collaborating across teams to enhance pipeline development.

Qualifications

• Experience in health technology appraisal (HTA) methods.
• Ability to deliver strategic recommendations for pipeline programs.
• Experience in market access and commercial strategy.

Responsibilities

• Deliver strategic recommendations on evidence requirements for pipeline assets.
• Support planning and execution of evidence generation in various markets.
• Collaborate with cross-functional teams for local insights in strategy.

Skills

Strong interpersonal skills

Technical knowledge of cost-effectiveness methods

Ability to work autonomously

Collaboration across multiple functions

Job description

Overview

Job title: Pipeline Value Demonstration Manager (Fixed Term – 12 months)

Reports to: Head of Appraisals and Pipeline Value Demonstration

Department: Market Access and Pricing

Summary

The Pipeline Value Demonstration Manager brings together technical knowledge of cost-effectiveness methods used in health technology appraisal (HTA) and a broader awareness of market access and commercial strategy to help shape the development of Takeda’s innovative pipeline. This is a highly collaborative role interacting with multiple internal functions at the Local Operating Country (LOC), Regional, and Global level as well as externally with health care professionals (HCPs) and patient advocacy groups (PAGs) to deliver prioritised, strategic recommendations for pipeline programs. The role requires proactivity, strong interpersonal skills, and the ability to work on a broad range of projects as you work autonomously and as part of larger teams across a wide range of therapeutic areas.

Responsibilities

• Deliver prioritised, strategic recommendations on the evidence requirements for pipeline assets (Phase 1 onwards) to Global Program Teams, based on patient, payer, prescriber and LOC needs.
• Support the shaping of clinical development programmes and Global evidence generation plans to ensure the evidence required for patient access in the UK (and cost-effectiveness-driven markets generally) is incorporated and consistent with the overarching commercial strategy and product value proposition.
• Validate, stress test and advise on Global access strategy, pricing, and launch scenarios, identifying key risks and opportunities
• Collaborate with cost-effectiveness LOCs to understand, collect, and consolidate their key evidence needs for HTA across the Takeda pipeline.
• Provide strategic guidance and support in the planning and execution of evidence generation activities in the UK, EUCAN, Global, and other cost-effectiveness markets where appropriate (ensuring compliance with UK requirements, where necessary).
• Support in the identification and early engagement of HCPs, PAGs, health economists and HTA experts to inform Global and local strategy and build long term relationships with Takeda.
• Collaborate across functions within the UK LOC (including New Product Planning) to ensure that local insights are embedded in Global pipeline asset strategy.
• Collaborate across functions (including New Product Planning) to drive early understanding of new disease backgrounds, therapeutic landscape, competitive intelligence, stakeholders, data sources and HTA landscape in the UK.
• Liaise across the UK and above country to ensure the UK Market Access team are kept informed regarding clinical development plans, evidence generation progress, launch timelines and regulatory pathways.
• Collaborate with Global and UK health economists to develop early economic models and support health economics-related activities; specifically, ensuring early modelling reflects the UK landscape and model scenarios can identify key model drivers and evidence gaps
• Lead priority early activities to support and enable broad, timely patient access to Takeda pipeline assets where appropriate (e.g. scientific advice, advisory boards, early access strategy development).
• Critique and / or run analyses and publish key scientific findings in high-impact journals, on topics including : Meta-analysis / extensive statistical analysisOutcome researchIndirect comparisonsHealth economic modelling
• Deputise, as appropriate, for the Head of Appraisals and Pipeline Value Demonstration at both external and internal meetings.
• Ensure continuous knowledge transfer of early pipeline development and strategy initiatives through to teams responsible for HTA submissions.

Therapeutic areas

• Gastroenterology
• Immunology
• Neuroscience
• Rare Diseases
• Haematology

Locations

London, Great Britain

Worker Type

Employee

Worker Sub-Type

Temporary / Limited Term

Time Type

Full time